Miguel Servet Hospital

Zaragoza 50009

0 studies enrolling now · 3 studies all time

What they study most

Follicular Lymphoma (FL), Ischemic Attack, Transient, Marginal Zone Lymphoma, Non Hodgkin Lymphoma, Platinum-resistant Ovarian Cancer

Studies at this site

• Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer — Running, not enrolling
• Zandelisib (ME-401) in Subjects With Follicular Lymphoma or Marginal Zone Lymphoma After Failure of Two or More Prior Therapies (TIDAL) — Stopped early
• Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial — Stopped early